LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $188,755 | +323.0% | 2,566 | +284.1% | 0.06% | +306.7% |
| Q4 2022 | $44,622 | +346.2% | 668 | +486.0% | 0.02% | +150.0% |
| Q2 2022 | $10,000 | -75.6% | 114 | -68.5% | 0.01% | -71.4% |
| Q1 2022 | $41,000 | -51.2% | 362 | -33.2% | 0.02% | -46.2% |
| Q4 2021 | $84,000 | +68.0% | 542 | +49.7% | 0.04% | +21.9% |
| Q3 2021 | $50,000 | +257.1% | 362 | +232.1% | 0.03% | +255.6% |
| Q2 2021 | $14,000 | – | 109 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |